Tenaya Therapeutics, Inc. (TNYA) Tops Q3 EPS by 8c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q3 EPS of ($0.39), $0.08 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Medtronic completes $550 million Scientia Vascular acquisition
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist